Literature DB >> 29315477

Enrichment of high affinity subclasses and glycoforms from serum-derived IgG using FcγRs as affinity ligands.

Austin W Boesch1,2, James H Kappel1, Alison E Mahan3, Thach H Chu1, Andrew R Crowley4, Nana Y Osei-Owusu4, Galit Alter3, Margaret E Ackerman1,4.   

Abstract

As antibodies continue to gain predominance in drug discovery and development pipelines, efforts to control and optimize their activity in vivo have matured to incorporate sophisticated abilities to manipulate engagement of specific Fc binding partners. Such efforts to promote diverse functional outcomes include modulating IgG-Fc affinity for FcγRs to alternatively potentiate or reduce effector functions, such as antibody-dependent cellular cytotoxicity and phagocytosis. While a number of natural and engineered Fc features capable of eliciting variable effector functions have been demonstrated in vitro and in vivo, elucidation of these important functional relationships has taken significant effort through use of diverse genetic, cellular and enzymatic techniques. As an orthogonal approach, we demonstrate use of FcγR as chromatographic affinity ligands to enrich and therefore simultaneously identify favored binding species from a complex mixture of serum-derived pooled polycloncal human IgG, a load material that contains the natural repertoire of Fc variants and post-translational modifications. The FcγR-enriched IgG was characterized for subclass and glycoform composition and the impact of this bioseparation step on antibody activity was measured in cell-based effector function assays including Natural Killer cell activation and monocyte phagocytosis. This work demonstrates a tractable means to rapidly distinguish complex functional relationships between two or more interacting biological agents by leveraging affinity chromatography followed by secondary analysis with high-resolution biophysical and functional assays and emphasizes a platform capable of surveying diverse natural post-translational modifications that may not be easily produced with high purity or easily accessible with recombinant expression techniques.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fc receptor; IgG; antibody; glycosylation; post-translational modification

Mesh:

Substances:

Year:  2018        PMID: 29315477      PMCID: PMC5906797          DOI: 10.1002/bit.26545

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  105 in total

1.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

2.  Assessment of naturally occurring covalent and total dimer levels in human IgG1 and IgG2.

Authors:  Jane Yang; Andrew M Goetze; Gregory C Flynn
Journal:  Mol Immunol       Date:  2013-12-08       Impact factor: 4.407

3.  Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Authors:  Guillaume Cartron; Laurent Dacheux; Gilles Salles; Philippe Solal-Celigny; Pierre Bardos; Philippe Colombat; Hervé Watier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

4.  Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcgamma receptors.

Authors:  Yin Luo; Zhaojiang Lu; Stephen W Raso; Clifford Entrican; Bruce Tangarone
Journal:  MAbs       Date:  2009-09-24       Impact factor: 5.857

5.  Post-translational modifications differentially affect IgG1 conformation and receptor binding.

Authors:  Damian Houde; Yucai Peng; Steven A Berkowitz; John R Engen
Journal:  Mol Cell Proteomics       Date:  2010-01-26       Impact factor: 5.911

6.  Highly parallel characterization of IgG Fc binding interactions.

Authors:  Austin W Boesch; Eric P Brown; Hao D Cheng; Maame Ofua Ofori; Erica Normandin; Peter A Nigrovic; Galit Alter; Margaret E Ackerman
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

7.  Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells.

Authors:  X Dong; W J Storkus; R D Salter
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

8.  Fc receptor-like A associates with intracellular IgG and IgM but is dispensable for antigen-specific immune responses.

Authors:  Timothy J Wilson; Susan Gilfillan; Marco Colonna
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

9.  Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics.

Authors:  Angela Schoch; Hubert Kettenberger; Olaf Mundigl; Gerhard Winter; Julia Engert; Julia Heinrich; Thomas Emrich
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

10.  Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.

Authors:  Tetyana Dashivets; Marco Thomann; Petra Rueger; Alexander Knaupp; Johannes Buchner; Tilman Schlothauer
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

View more
  6 in total

1.  FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus.

Authors:  Maud Maho-Vaillant; Magdalena Sips; Marie-Laure Golinski; Gestur Vidarsson; Matthias Goebeler; Johanna Stoevesandt; Zsuzsanna Bata-Csörgő; Bianca Balbino; Peter Verheesen; Pascal Joly; Michael Hertl; Sébastien Calbo
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

2.  Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV.

Authors:  Ali Danesh; Yanqin Ren; R Brad Jones
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

Review 3.  Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.

Authors:  Evan Rossignol; Galit Alter; Boris Julg
Journal:  J Infect Dis       Date:  2021-02-15       Impact factor: 5.226

Review 4.  Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation.

Authors:  Elizabeth Edwards; Maria Livanos; Anja Krueger; Anne Dell; Stuart M Haslam; C Mark Smales; Daniel G Bracewell
Journal:  Biotechnol Bioeng       Date:  2022-02-28       Impact factor: 4.395

5.  Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques.

Authors:  Justin Pollara; Matthew Zirui Tay; R Whitney Edwards; Derrick Goodman; Andrew R Crowley; Robert J Edwards; David Easterhoff; Haleigh E Conley; Taylor Hoxie; Thaddeus Gurley; Caroline Jones; Emily Machiele; Marina Tuyishime; Elizabeth Donahue; Shalini Jha; Rachel L Spreng; Thomas J Hope; Kevin Wiehe; Max M He; M Anthony Moody; Kevin O Saunders; Margaret E Ackerman; Guido Ferrari; Georgia D Tomaras
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

6.  Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies.

Authors:  Thach H Chu; Andrew R Crowley; Iara Backes; Cheryl Chang; Matthew Tay; Thomas Broge; Marina Tuyishime; Guido Ferrari; Michael S Seaman; Simone I Richardson; Georgia D Tomaras; Galit Alter; David Leib; Margaret E Ackerman
Journal:  PLoS Pathog       Date:  2020-02-24       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.